HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Busch, R. Articles by Mellins, E. D. Search for Related Content PubMed PubMed Citation Articles by Busch, R. Articles by Mellins, E. D. Social Bookmarking                      What's this?

J Biol Chem, Vol. 273, Issue 42, 27557-27564, October 16, 1998

Secondary Structure Composition and pH-dependent Conformational Changes of Soluble Recombinant HLA-DM

From the Department of Pediatrics and the ^§ Howard Hughes Medical Institute, Stanford University, Stanford, California 94305 and ^¶ Merck Research Laboratories, Rahway, New Jersey 07065

HLA-DM catalyzes the release of invariant chain fragments from newly synthesized major histocompatibility complex (MHC) class II molecules, stabilizes empty class II molecules, and edits class II-associated peptides by preferentially releasing those that are loosely bound. The ability of HLA-DM to carry out these functions in vitro is pH dependent, with an optimum at pH 4.5-5.5 and poor activity at pH 7. The structural basis for these properties of HLA-DM is unknown. Sequence homology suggests that HLA-DM resembles classical, peptide-binding MHC class II molecules. In this study, we examined whether HLA-DM has a secondary structure composition consistent with an MHC fold and whether HLA-DM changes conformation between pH 5 and pH 7. Far-UV circular dichroism (CD) spectra of recombinant soluble HLA-DM (sDM) indicate that HLA-DM belongs to the / class of proteins and structurally resembles both MHC class I and class II molecules. The CD peak around 198 nm increases upon going from neutral to endosomal pH and drops sharply upon denaturation below pH 3.5, distinguishing at least three states of sDM: the denatured state and two highly similar folded states. Fluorescence emission spectra show a slight blue-shift and a 20% drop in intensity at pH 5 compared with pH 7. Unfolding experiments using guanidinium chloride show that the stability of sDM is somewhat reduced but not lost at pH 5. These results indicate that sDM undergoes a pH-dependent conformational change between neutral and endosomal pH. The change seems to involve both hydrogen bonding patterns and the hydrophobic core of sDM and may contribute to the pH dependence of DM activity.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				G. M. Grotenbreg, M. J. Nicholson, K. D. Fowler, K. Wilbuer, L. Octavio, M. Yang, A. K. Chakraborty, H. L. Ploegh, and K. W. Wucherpfennig Empty Class II Major Histocompatibility Complex Created by Peptide Photolysis Establishes the Role of DM in Peptide Association J. Biol. Chem., July 20, 2007; 282(29): 21425 - 21436. [Abstract] [Full Text] [PDF]

				R. C. Doebele, A. Pashine, W. Liu, D. M. Zaller, M. Belmares, R. Busch, and E. D. Mellins Point Mutations in or Near the Antigen-Binding Groove of HLA-DR3 Implicate Class II-Associated Invariant Chain Peptide Affinity as a Constraint on MHC Class II Polymorphism J. Immunol., May 1, 2003; 170(9): 4683 - 4692. [Abstract] [Full Text] [PDF]

				O. Rotzschke, J. M. Lau, M. Hofstatter, K. Falk, and J. L. Strominger A pH-sensitive histidine residue as control element for ligand release from HLA-DR molecules PNAS, December 24, 2002; 99(26): 16946 - 16950. [Abstract] [Full Text] [PDF]

				M. P. Belmares, R. Busch, K. W. Wucherpfennig, H. M. McConnell, and E. D. Mellins Structural Factors Contributing to DM Susceptibility of MHC Class II/Peptide Complexes J. Immunol., November 1, 2002; 169(9): 5109 - 5117. [Abstract] [Full Text] [PDF]

				N. S. Patil, A. Pashine, M. P. Belmares, W. Liu, B. Kaneshiro, J. Rabinowitz, H. McConnell, and E. D. Mellins Rheumatoid Arthritis (RA)-Associated HLA-DR Alleles Form Less Stable Complexes with Class II-Associated Invariant Chain Peptide Than Non-RA-Associated HLA-DR Alleles J. Immunol., December 15, 2001; 167(12): 7157 - 7168. [Abstract] [Full Text] [PDF]

				D. A. Weber, C. T. Dao, J. Jun, J. L. Wigal, and P. E. Jensen Transmembrane Domain-Mediated Colocalization of HLA-DM and HLA-DR Is Required for Optimal HLA-DM Catalytic Activity J. Immunol., November 1, 2001; 167(9): 5167 - 5174. [Abstract] [Full Text] [PDF]

				J. A. Zarutskie, R. Busch, Z. Zavala-Ruiz, M. Rushe, E. D. Mellins, and L. J. Stern The kinetic basis of peptide exchange catalysis by HLA-DM PNAS, October 12, 2001; (2001) 211439398. [Abstract] [Full Text] [PDF]

				A. Faubert, A. Samaan, and J. Thibodeau Functional Analysis of Tryptophans alpha 62 and beta 120 on HLA-DM J. Biol. Chem., January 18, 2002; 277(4): 2750 - 2755. [Abstract] [Full Text] [PDF]

				J. A. Zarutskie, R. Busch, Z. Zavala-Ruiz, M. Rushe, E. D. Mellins, and L. J. Stern The kinetic basis of peptide exchange catalysis by HLA-DM PNAS, October 23, 2001; 98(22): 12450 - 12455. [Abstract] [Full Text] [PDF]